Diabetic cardiomyopathy: An overview

Coronary Artery Disease

Volumn 7, Issue 2, 1996, Pages 95-98

  LeWinter, Martin M ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOMYOPATHY; CLINICAL FEATURE; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030017167     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199602000-00001     Document Type: Review

References (44)

1. Kannel WB, Hjortland M, Castelli WP: Role of diabetes in congestive •• heart failure: the Framingham study. Am J Cardiol 1974, 34:29-34. This classic paper clearly identified diabetes as an independent risk factor for heart failure.
2. Jaffe AS, Spadaro J, Schechtman K, Roberts R, Geltman EM, Sobel BE: Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am Heart J 1984, 108:1-7.
3. Gwilt DJ, Petri M, Lewis PW, Nattrass M, Pentecost BL: Myocardial infarct size and mortality in diabetic patients. Br Heart J 1985, 54:466-472.
4. Orlander PR, Goff DC, Morrissey M, Ramsey DJ, Wear ML, Labarlte • DR, et al.: The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. Diabetes 1994, 43:897-902. A recent paper documenting continued high risk of postinfarction complications and death in diabetic patients.
5. Rubler S, Dlugash J, Yuceoglu Y, Kumral T, Branwood AW, Grishma A: New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972, 30:595-602.
6. Hamby RI, Zoneraich S, Sherman L: Diabetic cardiomyopathy. JAMA •• 1974, 229:1749-1759. This classic paper delineated the clinical features of diabetic cardiomyopathy.
7. Reagan TJ, Lyons MM, Ahmed SS, et al.: Evidence for cardiomyopathy •• In familial diabetes mellitus. J Clin Invest 1977, 60:885-899. This classic paper related clinical diabetic cardiomyopathy to pathologic changes.
8. Penpargkul S, Schaible T, Yipintsoi T, Scheuer J: The effect of diabetes on performance and metabolism of rat hearts. Circ Res 1980,47:911-921.
9. Fein FS, Kornstein LB, Strobeck JE, Capasso JM, Sonnenblick EH: Altered myocardial mechanics in diabetic rats. Circ Res 1980, 47:922-933.
10. Vadlamudi RVSV, Rodgers RL, McNeill JH: The effect of chronic alloxan- and streptozotocin-induced diabetes on isolated rat heart performance. Can J Physiol Pharmacol 1982, 60:902-911.
11. Schaffer SW, Tan BH, Wilson GL: Development of a cardiomyopathy •• in a model of noninsulin-dependent diabetes. Am J Physiol 1985, 248:H179-H185. A cardiomyopathy was described in an animal model of non-insulin-dependent diabetes.
12. Penpargkul S, Fein F, Sonnenblick EH, Scheuer J: Depressed cardiac •• sarcoplasmic reticular function from diabetic rats. J Mol Cell Cardiol 1981, 13:303-309. This early study indicated abnormal myocardial calcium handling in experimental diabetes.
13. Ganguly PK, Pierce GN, Dhalla KS, Dhalla NS: Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol 1983, 244:E528-E535.
14. 2+ channel. Cardiovasc Res 1990, 24:381-389.
15. Bouchard RA, Bose D: Influence of experimental diabetes on • sarcoplasmic reticulum function in rat ventricular muscle. Am J Physiol 1991, 260:H341-H354. Abnormal sarcoplasmic reticular function was studied more recently in experimental diabetes.
16. Allo SN, Lincoln TM, Wilson GL, Green FJ, Watanabe AM, Schaffer SW: Non-insulin-dependent diabetes-induced defects in cardiac cellular calcium regulation. Am J Physiol 1991, 260:C1165-C1177.
17. Regan TJ, Ettinger PO, Khan MI, et al.: Altered myocardial function and •• metabolism in chronic diabetes mellitus without ischemia in dogs. Circ Res 1974, 35:222-237. This is a report of the first study of experimental diabetic cardiomyopathy in a large animal model.
18. Regan TJ, Wu CF, Yeh CK: Myocardial composition and function in diabetes. Circ Res 1981, 49:1268-1277.
19. Haider B, Ahmed SS, Moschos CB, et al.: Myocardial function and coronary blood flow response to acute ischemia in chronic canine diabetes. Circ Res 1977, 40:577-583.
20. Haider B, Yeh CK, Thomas G, Oldewurtel HA, Lyons MM, Ryan TJ: Influence of diabetes on the myocardium and coronary arteries of Rhesus monkey fed an atherogenic diet Circ Res 1981. 49:1278-1288.
21. Mulieri LA, Hasenfuss G, Leavitt B, Allen PD, Alpert NR: Altered myocardial force-frequency relation in human heart failure. Circulation 1992, 85:1743-1750.
22. Fisher BM, Gillen G, Lindop GBM, Dargie HJ, Frier BM: Cardiac • function and coronary arteriography in asymptomatic type 1 (insulin-dependent) diabetic patients: evidence for a specific diabetic heart disease. Diabetologia 1986, 29:706-712. This important study provided evidence of cardiomyopathy in asymptomatic diabetic patients who had normal coronary arteriography.
23. Kahn JK, Zola B, Juni JW, Vinik AI: Radionuclide assessment of left ventricular diastolic filling in diabetes mellitus with and without cardiac autonomic neuropathy. J Am Coll Cardiol 1986, 7:1303-1309.
24. Paillole C, Dahan M, Paycha F, Solal AC, Passa P, Gourgon R: Prevalence and significance of left ventricular filling abnormalities determined by Doppler echocardiography in young type I (insulin-dependent) diabetic patients. Am J Cardiol 1989, 64:1010-1016.
25. Borow KM, Jaspan JB, Williams KA, Neumann A, Wolinski-Walley P, Lang RM: Myocardial mechanics in young adult patients with diabetes mellitus: effects of altered load, inotropic state and dynamic exercise. J Am Coll Cardiol 15:1508-1517.
26. Galderisi M, Anderson KM, Wilson PWF, Levy D: Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol 1991, 68:85-89.
27. Fraser GE, Luke R, Thompson S, Smith H, Carter S, Sharpe N: Comparison of echocardiographic variables between type I diabetes and normal controls. Am J Cardiol 1995, 75:141-145
28. Perez JE, McGill JB, Santiago JV, Schechtman KB, Waggoner AD, Miller •• JG, Sobel BE: Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. J Am Coll Cardiol 1992, 19:1154-1162. Both abnormal echocardiographic tissue characterization and abnormal Doppler filling parameters were demonstrated in asymptomatic diabetic patients.
29. Bibello V, Talarico L, Picano E, di Muro C, Landini L, Paterni M, et al.: Increased echodensity of myocardial wall in the diabetic heart: an ultrasound tissue characterization study. J Am Coll Cardiol 1995, 25:1408-1415.
30. Vered Z, Battler A, Segal P, Liberman D, Yerushelmi Y, Berezin M, et al.: Exercise-induced left ventricular dysfunction in young men with asymptomatic diabetes mellitus (diabetic cardiomyopathy). Am J Cardiol 1984, 54:633-637.
31. Factor SM, Minase T, Sonnenblick EH: Clinical and morphological features of human hypertensive-diabetic cardiomyopathy. Am Heart J 1980, 99:446-458.
32. Fein FS, Sonnenblick EH: Diabetic cardiomyopathy. Prog Cardiovasc •• Dis 1985, 27:255-270. This is an excellent review of pathologic-clinical correlates in diabetes.
33. Tahiliani AG, McNeill JH: Prevention of diabetes-induced myocardial dysfunction in rats by methylpalmoxirate and triodothyronine treatment Can J Physiol Pharmacol 1985, 63:925-931.
34. Rosen P, Windeck P, Zimmer H-G, Frenzel H, Burrig KF, Reinauer H: Myocardial performance and metabolism in non-ketotic, diabetic rat hearts: myocardial function and metabolism in vivo and in the isolated perfused heart under the influence of insulin and octanoate. Basic Res Cardiol 1986, 81:620-635.
35. Rodrigues B, Xiang H, McNeill JH: Effect of L-carnitine treatment on • lipid metabolism and cardiac performance in chronically diabetic rats. Diabetes 1988, 37:1358-1364. An experimental study delineating the potential role of lipid metabolism abnormalities in diabetic cardiomyopathy.
36. Lopaschuk GD, Spafford M: Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow in acutely and chronically diabetic rets. Circ Res 1989, 65:378-387.
37. Nicholl TA, Lopaschuk GD, McNeill JH: Effects of free fatty acids and dichloracetate on isolated working diabetic rat heart. Am J Physiol 1991, 261:H1053-H1059.
38. Rodrigues B, McNeill JH: The diabetic heart: metabolic causes for the • development of a cardiomyopathy. Cardiovasc Res 1992, 26:913-922. The authors present an excellent review of metabolic abnormalities in the diabetic heart.
39. Nakamura Y, Horii Y, Nishino T, Shiiki H, Sakaguchi Y, Kagoshima T, et al.: Immunohistochemical localization of advanced glycosylation endproducts in coronary atheroma and cardiac tissue In diabetes mellitus. Am J Pathol 1993, 143:1649-1656.
40. Brownlee M: Glycation and diabetic complications. Diabetes 1994, •• 43:836-841. An excellent review of the role of glycation in diabetic complications is presented.
41. Porta M, La Selva M, Molinatti P, Molinatti GM: Endothelial cell function in diabetic microangiopathy. Diabetologia 1987, 30:601-609.
42. Cohen R: Dysfunction of vascular endothelium in diabetes mellitus. •• Circulation 1993, 87 (suppl V):67-76. Endothelial dysfunction in diabetes is reviewed thoroughly.
43. Schneider DJ, Nordt TK, Sobel BE: Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes 1993, 42:1-7.
44. Dzau VJ: Local contractile and growth modulators in the myocardium. Clin Cardiol 1993, 16 (suppl 2):5-12.